课题基金 / 基金详情

Development of novel blast resistant wheat varieties for Bangladesh by genome editing

Development of novel blast resistant wheat varieties for Bangladesh by genome editing
通过基因组编辑为孟加拉国开发新型抗稻瘟病小麦品种
批准号:
BB/P023339/2
负责人:
Nicholas Talbot
金额:
$37.19万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

Nicholas Talbot的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Wheat blast is a devastating disease that appeared for the first time in Bangladesh in February 2016. In a very short period of time the disease has already destroyed 15,000 Hectares of wheat. Farmers have resorted to burning wheat fields to try to prevent wheat blast from spreading. This is a potentially catastrophic situation in one of the world's poorest countries. Unless wheat blast is controlled, the disease threatens wheat production, not only in Bangladesh, but right across Asia. An urgent response to wheat blast disease is required.As soon as news of the outbreak emerged, the co-applicants of this proposal formed a collaboration with Prof. Md. Tofazzal Islam of Bangabanhu Sheikh Mujibur Rahman Agricultural University (BSMRAU) in Bangladesh and obtained diseased material to identify the origin of the wheat blast disease. This demonstrated that wheat blast in Bangladesh is caused by a fungus that has spread from South America, probably by importation of infected wheat grain. This Global Challenges Research Fund project describes a novel strategy that we believe offers the most rapid means by which wheat blast could be controlled. We aim to use the very latest genome editing methods to modify wheat plants so that they are able to resist fungal infection. We have identified potential disease susceptibility factors which, if modified (or removed), may make wheat plants better able to defend themselves against wheat blast. This is a novel approach, which would result in non-GM wheat varieties, which can be provided to farmers very quickly. We aim to work with scientists and agricultural professionals in Bangladesh to make sure we can apply the advanced genome editing methods in this project within Bangladesh and train scientists there to use the procedures routinely. We will also work with local agricultural extension services to work out the best way to make wheat varieties generated in the project available to farmers as rapidly as possible, and at the scale necessary to halt this devastating disease.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pbio.3002052
发表时间: 2023-04
期刊: PLoS biology
影响因子: 9.8
作者: []
通讯作者:
Ten things we learned in 2010-2019 (aside from everything else)
2010-2019 年我们学到的十件事(抛开其他一切)
DOI: 10.5281/zenodo.3613856
发表时间: 2020
期刊:
影响因子: --
作者: [Kamoun S]
通讯作者: Kamoun S
BBSRC Institute Strategic Programme: Advancing Plant Health (APH) Partner Grant
  • 批准号:
    BB/Y002997/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $625.59万
  • 财政年份:
    2023
  • 负责人:
    Nicholas Talbot
  • 依托单位:
SEPBLAST: Determining the molecular basis of septin-dependent plant infection by the blast fungus Magnaporthe oryzae
  • 批准号:
    EP/X022439/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $274.53万
  • 财政年份:
    2022
  • 负责人:
    Nicholas Talbot
  • 依托单位:
Investigating the role of the Sln1 turgor sensor kinase in the rice blast fungus Magnaporthe oryzae
  • 批准号:
    BB/V016342/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $80.21万
  • 财政年份:
    2022
  • 负责人:
    Nicholas Talbot
  • 依托单位:
Durable Rice Blast Resistance for Sub-Saharan Africa
  • 批准号:
    BB/R020698/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $191.35万
  • 财政年份:
    2018
  • 负责人:
    Nicholas Talbot
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: